Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Liabilities (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $73000.0 as the latest value for Q4 2024.

  • Quarterly Other Non-Current Liabilities fell 99.71% to $73000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $73000.0 through Dec 2024, down 99.71% year-over-year, with the annual reading at $73000.0 for FY2024, 99.71% down from the prior year.
  • Other Non-Current Liabilities for Q4 2024 was $73000.0 at Artiva Biotherapeutics, roughly flat from $73000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $25.1 million in Q4 2023, with the low at $73000.0 in Q3 2024.